1 / 17

GR Burstein 1 , MA Snyder 2 , D Conley 2 , DR Newman 1 , CM Walsh 1 , G Tao 1 , K Irwin 1

Screening Rates Before and After the Introduction of the Chlamydia HEDIS Measure in a Managed Care Organization. GR Burstein 1 , MA Snyder 2 , D Conley 2 , DR Newman 1 , CM Walsh 1 , G Tao 1 , K Irwin 1 1 Centers for Disease Control and Prevention 2 Kaiser Permanente Mid-Atlantic States.

coty
Download Presentation

GR Burstein 1 , MA Snyder 2 , D Conley 2 , DR Newman 1 , CM Walsh 1 , G Tao 1 , K Irwin 1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Screening Rates Before and After the Introduction of the Chlamydia HEDIS Measure in a Managed Care Organization GR Burstein1, MA Snyder2, D Conley2, DR Newman1, CM Walsh1, G Tao1, K Irwin1 1Centers for Disease Control and Prevention 2Kaiser Permanente Mid-Atlantic States

  2. Background

  3. Health Plan Employer Data and Information Set (HEDIS) is a a tool used to measure managed care organization (MCO) performance in key areas. HEDIS is supported by the National Center for Quality Assurance (NCQA) independent non-profit organization whose mission is to improve US health care quality Almost 90% of health plans measure their performance using HEDIS. HEDIS

  4. In 2000, a new HEDIS performance measure was introduced to monitor the proportion of sexually active 15-26 year-old females screened annually for chlamydia.

  5. To determine changes after introduction of the HEDIS measure in a large MCO in: chlamydia screening policies chlamydia testing practices chlamydia positivity rates Objectives

  6. We reviewed electronic medical records of a large, not-for-profit MCO for 15-26 year-old females who were classified as sexually active according to administrative data elements specified by HEDIS Endocervical chlamydia tests (DNA probe; GenProbe, San Diego, CA) performed during 1998-2001 Methods

  7. We used chi-square testing to compare chlamydia screening rates and positive tests for the 2 years before (1998-9) and after (2000-1) the introduction of the chlamydia HEDIS measure. We queried MCO departmental chiefs about practice changes implemented to meet the new HEDIS measure. Methods

  8. Employer-based, not-for-profit MCO plan serves primary working people and their dependents no Medicaid beneficiaries Serves diverse population 21 clinics in Baltimore City, Washington DC, Maryland and Northern Virginia suburbs Offers unrestricted access to OB-GYN services Provides confidential adolescent reproductive health care services Explanation of Benefits not sent home which avoids breech of confidentiality about sexual activity/sexual health services Require adolescent permission to release confidential information Kaiser Permanente Mid-Atlantic States

  9. Results

  10. 15-26 Year Old Females Who Were MCO Members, Members Classified as Sexually Active (SA) by HEDIS Criteria and Tested for Chlamydia trachomatis, 1998-2001. *p<0.0001

  11. OB-GYN instituted policy of collecting a chlamydia test at the same time as a Pap test on 15-26 y.o. females policy operationalized by nursing assistants automatically placing a chlamydia collection swab next to Pap collection materials Other primary care specialties Internal Medicine and Family Practice advised providers to perform chlamydia tests with Pap smears on 15-26 y.o. females policy merely articulated but was not operationalized within their practices Pediatrics offered providers adolescent heath care training Changes in MCO Chlamydia Screening Policies by Specialty

  12. Type of Specialty Care Received by Adolescent Female Members 15-26 Years Old Classified as Sexually Active by HEDIS Criteria, 1998-2001 Type of Specialty Care

  13. Proportion of Sexually Active 15-26 Year Old Female MCO Members Tested for Chlamydia in Specialty Departments, 1998-2001 % of SA ♀ MCO Members CT Tested Who Were Seen inSingle Specialty Care VisitsBoth Primary Care & OB-GYN Visits *p<0.0001

  14. Chlamydia Tests Performed Among Female 15-26 Year Old MCO Members Who Received Paps, Pregnancy Tests, or Filled Contraceptive Prescriptions, 1998-2001 *p<0.00001

  15. Proportion of Positive Chlamydia trachomatis tests Among MCO Female Members 15-26 Years Old, 1998-2001 Proportion of Positive C. trachomatis Tests *171 more cases detected

  16. Following HEDIS measure introduction in this MCO, % of sexually active 15-26 year-old females tested for chlamydia increased overall with little change in the % of positive tests Most of the increase resulted from the new OB-GYN policy of performing chlamydia screening with routine Pap tests Conclusions

  17. Simple systems changes and access to OB-GYN providers can improve chlamydia screening rates and detect a significant number of asymptomatic infections in an MCO Operationalizing policy in the health system is key to change Implications for Programs & Policy

More Related